Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts-Reference-Cited by-同舟云学术

Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts

Published:2015-10-07 Issue: Volume: Page:bgv146
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:CARCIN

Author:

Vizoso Miguel,Puig Marta,Carmona F.Javier,Maqueda María,Velásquez Adriana,Gómez Antonio,Labernadie Anna,Lugo Roberto,Gabasa Marta,Rigat-Brugarolas Luis G.,Trepat Xavier,Ramírez Josep,Moran Sebastian,Vidal Enrique,Reguart Noemí,Perera Alexandre,Esteller Manel,Alcaraz Jordi

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/36/12/1453/17293714/bgv146.pdf

Reference50 articles.

1. Non-small-cell lung cancers: a heterogeneous set of diseases

2. Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression;Bissell;Nat. Med,2012

3. Co-evolution of tumor cells and their microenvironment

4. Fibroblast heterogeneity in the cancer wound

5. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Based on machine learning, CDC20 has been identified as a biomarker for postoperative recurrence and progression in stage I & II lung adenocarcinoma patients;Frontiers in Oncology;2024-07-24

2. Novel Semi-Nested Real-Time PCR Assay Leveraging Extendable Blocking Probes for Improved SHOX2 Methylation Analysis in Lung Cancer;Biomolecules;2024-06-19

3. Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma;Cancer Science;2024-03-12

4. Cancer-associated fibroblasts reveal aberrant DNA methylation across different types of cancer;2024-02-07

5. Epigenetic regulation in cancer;MedComm;2024-02